ImmunityBio Announces Approval in Macau SAR, China for ANKTIVA® in BCG-Unresponsive NMIBC with CIS ± Papillary Tumors
businesswire.com
⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in